Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“Dentsply”) securities between November 4, 2021 and May 9, 2022.
Dentsply investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.
On April 11, 2022, Dentsply issued a press release announcing that Jorge M. Gomez, the company’s Executive Vice President and Chief Financial Officer had resigned from his position, effective May 6, 2022. Then, on April 19, 2022, Dentsply issued another press release announcing that its Chief Executive Officer, Donald M. Casey Jr., had been terminated and would cease to serve as a member of the Board of Directors, effective immediately. Following this news, Dentsply’s stock fell $6.52, or 13.4%, to close at $42.20 per share on April 19, 2022.
Then, on May 10, 2022, Dentsply announced that it could not timely file its first quarter 2022 quarterly report due to “an internal investigation of allegations regarding certain financial reporting matters.” Specifically, the investigation concerns the company’s use of incentives to sell products to distributors in the third and fourth quarters of 2021 and whether those incentives were appropriately accounted for and the impact of those sales was adequately disclosed. In addition, the investigation concerns allegations that certain former and current members of senior management directed the company’s use of incentives and other actions to achieve executive compensation targets in 2021. Following this news, Dentsply’s stock fell as much as 10% during intraday trading on May 10, 2022.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.